Crosslinked Biodegradable Hybrid Hydrogels Based on Poly(ethylene glycol) and Gelatin for Drug Controlled Release
Molecules · 19.10.2024 · 29 (20) · 4952
DOI: 10.3390/molecules29204952 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 19.10.2024. Verfasst von Zhenzhen Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Advanced Agricultural Science, Weifang University, Weifang 261061, China. Hauptthemen laut MEDLINE: Hydrogels, Polyethylene Glycols, Gelatin, Drug Liberation. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key R&D Program of Shandong Province, Weifang University Doctor Initiation Fund Project, Key Research and Development Project of Hainan Province, China.
Abstract (Originalsprache)
A series of hybrid hydrogels of poly(ethylene glycol) (PEG) were synthesized using gelatin as a crosslinker and investigated for controlled delivery of the first-generation cephalosporin antibiotic, Cefazedone sodium (CFD). A commercially available 4-arm-PEG–OH was first modified to obtain four-arm-PEG–succinimidyl glutarate (4-arm-PEG–SG), which formed the gelatin–PEG composite hydrogels (SnNm) through crosslinking with gelatin. To regulate the drug delivery, SnNm hydrogels with various solid contents and crosslinking degrees were prepared. The effect of solid contents and crosslinking degrees on the thermal, mechanical, swelling, degradation, and drug release properties of the hydrogels were intensively investigated. The results revealed that increasing the crosslinking degree and solid content of SnNm could not only enhance the thermal stability, swelling ratio (SR), and compression resistance capacity of SnNm but also prolong the degradation and drug release times. The release kinetics of the SnNm hydrogels were found to follow the first-order model, suggesting that the transport rate of CFD within the matrix of hydrogels is proportional to the concentration of the drug where it is located. Specifically, S1N1-III showed 90% mass loss after 60 h of degradation and a sustained release duration of 72 h. The cytotoxicity assay using the MTT method revealed that cell viability rates of S1N1 were higher than 95%, indicating excellent cytocompatibility. This study offers new insights and methodologies for the development of hydrogels as biomedical composite materials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Advanced Agricultural Science, Weifang University, Weifang 261061, China.
- College of Chemistry, Chemical Engineering and Materials Science, Shandong Normal University, Jinan 250014, China.
- Key Laboratory of Ministry of Education for Advanced Materials in Tropical Island Resources, Hainan University, Haikou 570228, China.
ORCID-Profile: Zhenzhen Zhao, Zhaosheng Hou, Yanan Gao
Förderung
- Key R&D Program of Shandong Province
- Weifang University Doctor Initiation Fund Project
- Key Research and Development Project of Hainan Province, China
- Major Science and Technology Plan of Hainan Province, China
- Key R&D Program of Shandong Province
Zitieren
APA
Zhao, Z., Qin, Z., Zhao, T., Li, Y., Hou, Z., Hu, H., Su, X., & Gao, Y. (2024). Crosslinked Biodegradable Hybrid Hydrogels Based on Poly(ethylene glycol) and Gelatin for Drug Controlled Release. Molecules, 29(20), 4952. https://doi.org/10.3390/molecules29204952
Vancouver
Zhao Z, Qin Z, Zhao T, Li Y, Hou Z, Hu H, et al. Crosslinked Biodegradable Hybrid Hydrogels Based on Poly(ethylene glycol) and Gelatin for Drug Controlled Release. Molecules. 2024;29(20):4952. doi:10.3390/molecules29204952
BibTeX
@article{Zhao2024,
author = {Zhao, Zhenzhen and Qin, Zihao and Zhao, Tianqing and Li, Yuanyuan and Hou, Zhaosheng and Hu, Hui and Su, Xiaofang and Gao, Yanan},
title = {Crosslinked Biodegradable Hybrid Hydrogels Based on Poly(ethylene glycol) and Gelatin for Drug Controlled Release},
journal = {Molecules},
year = {2024},
volume = {29},
number = {20},
pages = {4952},
doi = {10.3390/molecules29204952}
}
EUVIMED